The vast majority of the tumor biopsies classified as IDH-mutant gliomas (94%, 29/31) had a calibrated family score ≥0.90 (max 1.0) but the median tumor purity differed between the methods (Fig. 2). This evidence concerns the gene IDH1 and central nervous system cancer.